Transaction in Own Shares

PureTech Health PLC

17 November 2023

 

17 November 2023

PureTech Health plc

Transaction in Own Shares

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Date of purchase:	16 November 2023
Number of ordinary shares purchased:	25,140
Highest price paid per share:	182.20p
Lowest price paid per share:	176.80p
Volume weighted average price paid per share:	179.00p

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,310,999 ordinary shares in treasury and has 273,157,160 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 273,157,160 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

Contact:

PureTech

Investor Relations

[e-mail]

Individual Transactions

Transaction Date	Transaction Time	Volume	Price (GBp)	Platform	Transaction Reference Number
16/11/2023	11:47:14	189	182.2	AQXE	00378647894TRLO0.1.1
16/11/2023	11:47:14	44	182.2	XLON	00378647893TRLO0.1.1
16/11/2023	11:47:14	189	182.2	AQXE	00378647895TRLO0.1.1
16/11/2023	11:47:14	492	182.2	XLON	00378647896TRLO0.1.1
16/11/2023	11:47:14	96	182.2	TRQX	00378647898TRLO0.1.1
16/11/2023	11:47:14	96	182.2	TRQX	00378647897TRLO0.1.1
16/11/2023	11:49:35	536	182	CHIX	00378648134TRLO0.1.1
16/11/2023	11:49:43	36	181	BATE	00378648139TRLO0.1.1
16/11/2023	11:49:44	439	181	BATE	00378648140TRLO0.1.1
16/11/2023	11:55:04	536	180	XLON	00378648676TRLO0.1.1
16/11/2023	12:09:09	108	179	XLON	00378651730TRLO0.1.1
16/11/2023	12:09:09	428	179	XLON	00378651731TRLO0.1.1
16/11/2023	12:09:09	536	179	XLON	00378651732TRLO0.1.1
16/11/2023	12:19:03	765	178	XLON	00378653296TRLO0.1.1
16/11/2023	12:19:03	307	178	XLON	00378653295TRLO0.1.1
16/11/2023	12:24:44	56	178.2	XLON	00378653918TRLO0.1.1
16/11/2023	12:25:46	55	178.2	XLON	00378653993TRLO0.1.1
16/11/2023	12:53:12	253	177.6	XLON	00378657008TRLO0.1.1
16/11/2023	13:04:18	229	177.6	XLON	00378658168TRLO0.1.1
16/11/2023	13:14:46	822	177.6	XLON	00378659705TRLO0.1.1
16/11/2023	13:14:46	304	177.6	XLON	00378659704TRLO0.1.1
16/11/2023	13:14:47	445	178.4	CHIX	00378659715TRLO0.1.1
16/11/2023	13:23:22	68	178.4	CHIX	00378660803TRLO0.1.1
16/11/2023	13:23:22	559	178.4	CHIX	00378660804TRLO0.1.1
16/11/2023	14:13:01	44	181.4	CHIX	00378668034TRLO0.1.1
16/11/2023	14:15:00	738	181.4	CHIX	00378668283TRLO0.1.1
16/11/2023	14:15:00	290	181.4	CHIX	00378668282TRLO0.1.1
16/11/2023	14:16:51	62	180.6	AQXE	00378668555TRLO0.1.1
16/11/2023	14:16:51	44	180.6	AQXE	00378668556TRLO0.1.1
16/11/2023	14:16:51	1608	180.8	XLON	00378668557TRLO0.1.1
16/11/2023	14:16:53	83	180.6	AQXE	00378668560TRLO0.1.1
16/11/2023	14:30:06	1333	180	XLON	00378671318TRLO0.1.1
16/11/2023	14:30:06	275	180	XLON	00378671317TRLO0.1.1
16/11/2023	14:30:06	96	180	TRQX	00378671319TRLO0.1.1
16/11/2023	14:35:52	535	179.6	BATE	00378673323TRLO0.1.1
16/11/2023	14:35:52	189	179.6	AQXE	00378673322TRLO0.1.1
16/11/2023	14:35:54	469	179.6	BATE	00378673329TRLO0.1.1
16/11/2023	14:35:56	399	179.4	XLON	00378673341TRLO0.1.1
16/11/2023	14:35:58	230	179.4	XLON	00378673358TRLO0.1.1
16/11/2023	14:36:22	1515	179.4	XLON	00378673484TRLO0.1.1
16/11/2023	14:36:22	8	178.8	TRQX	00378673485TRLO0.1.1
16/11/2023	14:36:22	96	178.8	TRQX	00378673486TRLO0.1.1
16/11/2023	14:38:53	44	177	XLON	00378674986TRLO0.1.1
16/11/2023	14:38:59	1093	177	XLON	00378675043TRLO0.1.1
16/11/2023	14:38:59	1007	177	XLON	00378675044TRLO0.1.1
16/11/2023	15:18:11	39	178.8	AQXE	00378701571TRLO0.1.1
16/11/2023	15:19:35	150	178.8	AQXE	00378702453TRLO0.1.1
16/11/2023	15:26:20	555	178.8	CHIX	00378706657TRLO0.1.1
16/11/2023	15:37:44	359	178.8	XLON	00378711360TRLO0.1.1
16/11/2023	15:55:03	20	179	AQXE	00378717258TRLO0.1.1
16/11/2023	16:00:27	189	178	AQXE	00378718912TRLO0.1.1
16/11/2023	16:00:27	121	178	AQXE	00378718913TRLO0.1.1
16/11/2023	16:02:47	458	178.8	XLON	00378719557TRLO0.1.1
16/11/2023	16:14:20	421	178	BATE	00378725757TRLO0.1.1
16/11/2023	16:20:54	483	178	XLON	00378728660TRLO0.1.1
16/11/2023	16:21:08	536	178	CHIX	00378728773TRLO0.1.1
16/11/2023	16:21:08	362	178	XLON	00378728774TRLO0.1.1
16/11/2023	16:21:08	763	178	XLON	00378728775TRLO0.1.1
16/11/2023	16:21:09	96	177	TRQX	00378728785TRLO0.1.1
16/11/2023	16:21:09	189	176.8	AQXE	00378728801TRLO0.1.1
16/11/2023	16:21:09	522	178	BATE	00378728802TRLO0.1.1
16/11/2023	16:21:26	6	177.8	BATE	00378728983TRLO0.1.1
16/11/2023	16:22:22	83	177.6	BATE	00378729524TRLO0.1.1
16/11/2023	16:23:37	240	177.6	CHIX	00378730195TRLO0.1.1
16/11/2023	16:23:37	72	177.6	CHIX	00378730194TRLO0.1.1
16/11/2023	16:23:37	240	177.6	CHIX	00378730196TRLO0.1.1
16/11/2023	16:24:45	266	177.6	CHIX	00378730962TRLO0.1.1
16/11/2023	16:24:45	240	177.6	CHIX	00378730963TRLO0.1.1
16/11/2023	16:27:08	265	177.6	CHIX	00378732578TRLO0.1.1
16/11/2023	16:27:08	125	177.6	CHIX	00378732579TRLO0.1.1
16/11/2023	16:29:37	503	177.6	BATE	00378733908TRLO0.1.1
16/11/2023	16:29:37	37	177.6	BATE	00378733909TRLO0.1.1
16/11/2023	16:29:37	30	177.6	BATE	00378733910TRLO0.1.1
16/11/2023	16:29:40	24	177.6	BATE	00378734059TRLO0.1.1

 

END